ART initiation | 1 year post-initiation | |||||
---|---|---|---|---|---|---|
Male, n(%) | Female, n(%) | Total, n(%) | Male, n(%) | Female, n(%) | Total, n(%) | |
N | 146 | 156 | 302 | 114 | 112 | 226 |
Age (years) | ||||||
6–8 | 34 (23.2) | 26 (16.7) | 60 (19.9) | 15 (13.2) | 7 (6.3) | 22 (9.7) |
9–11 | 46 (31.5) | 61 (39.1) | 107 (35.4) | 34 (29.8) | 36 (32.1) | 70 (31.0) |
12–13 | 34 (23.3) | 35 (22.4) | 69 (22.9) | 23 (20.2) | 33 (29.5) | 56 (24.8) |
14–17 | 32 (21.9) | 33 (21.8) | 66 (21.9) | 42 (36.8) | 36 (32.1) | 78 (34.5) |
HAZ | ||||||
Mean (SD) Range | −1.80 (1.18) − 4.5 to 1.3 | − 1.52 (1.08) −5.0 to 1.4 | −1.65 (1.13) − 5.0 to 1.4 | −1.76 (1.12) − 4.2 to 1.1 | −1.53 (1.08) − 4.6 to 0.8 | −1.65 (1.10) − 4.6 to 1.1 |
Below − 3 | 25 (17.1) | 11 (7.1) | 36 (11.9) | 20 (17.5) | 11 (9.8) | 31 (13.7) |
− 3 to <− 2 | 29 (19.9) | 40 (25.6) | 69 (22.9) | 20 (17.5) | 23 (20.5) | 43 (19.0) |
−2 to <−1 | 55 (37.7) | 57 (36.5) | 112 (37.1) | 45 (39.5) | 42 (37.5) | 87 (38.5) |
−1 and above | 37 (25.3) | 48 (30.1) | 85 (28.2) | 29 (25.4) | 36 (32.1) | 65 (28.8) |
Stunted (<−2) | 54 (37.0) | 51 (32.7) | 105 (34.8) | 40 (35.1) | 34 (30.4) | 74 (32.7) |
WAZ | ||||||
Mean (SD) range | −1.81 (1.22) −4.3 to 0.4 | −1.39 (1.11) − 4.5 to 1.0 | −1.59 (1.18) − 4.5 to 1.0 | −1.72 (1.13) − 4.5 to 0.7 | −1.17 (1.07) − 4.2 to 0.9 | −1.45 (1.13) − 4.5 to 0.9 |
Below −3 | 29 (20.6) | 16 (10.3) | 45 (15.2) | 18 (16.1) | 7 (6.4) | 25 (11.3) |
−3 to <− 2 | 30 (21.3) | 27 (17.4) | 57 (19.3) | 23 (20.5) | 15 (13.8) | 38 (17.2) |
−2 to <−1 | 39 (27.7) | 53 (34.2) | 92 (31.1) | 38 (33.9) | 37 (33.9) | 75 (33.9) |
−1 and above | 43 (30.5) | 59 (38.1) | 102 (34.5) | 33 (29.5) | 50 (45.9) | 83 (37.6) |
Missing | 5 | 1 | 6 | 2 | 3 | 5 |
Underweight (<−2) | 59 (41.8) | 43 (27.7) | 102 (34.5) | 41 (36.6) | 22 (18.5) | 63 (28.5) |
BAZ | ||||||
Mean (SD) range | −1.11 (1.17) −4.6 to 1.4 | −0.72 (1.06) −4.3 to 1.3 | −0.91 (1.12) − 4.6 to 1.4 | −0.97 (1.00) −3.6 to 0.8 | −0.42 (0.99) − 2.9 to 1.6 | − 0.70 (1.03) − 3.6 to 1.6 |
Below − 3 | 12 (8.4) | 5 (3.2) | 17 (5.7) | 6 (5.3) | 0 | 6 (2.7) |
−3 to <−2 | 14 (9.8) | 14 (9.0) | 28 (9.4) | 11 (9.7) | 9 (8.3) | 20 (9.0) |
−2 to <−1 | 48 (33.6) | 35 (22.6) | 83 (27.9) | 34 (30.1) | 17 (15.6) | 51 (23.0) |
−1 and above | 69 (48.3) | 101 (65.2) | 170 (57.1) | 62 (54.9) | 83 (76.2) | 145 (65.3) |
Missing | 3 | 1 | 4 | 1 | 3 | 4 |
Wasted (<−2) | 26 (18.2) | 19 (12.3) | 45 (15.1) | 17 (15.0) | 9 (8.3) | 26 (11.7) |
CD4 count | ||||||
< 200 | 41 (30.4) | 47 (32.2) | 88 (31.3) | 10 (14.7) | 12 (16.4) | 22 (15.6) |
200–349 | 44 (32.6) | 46 (31.5) | 90 (32.0) | 4 (5.9) | 13 (17.8) | 17 (12.1) |
350–499 | 35 (25.9) | 36 (24.7) | 71 (25.3) | 16 (23.5) | 7 (9.6) | 23 (16.3) |
500+ | 15 (11.1) | 17 (11.6) | 32 (11.4) | 38 (55.9) | 41 (56.2) | 79 (56.0) |
Missing | 11 | 10 | 21 | 46 | 39 | 85 |
Ever diagnosed with TB | ||||||
Yes | 9 (6.2) | 9 (5.8) | 18 (6.0) | 7 (6.1) | 6 (5.4) | 13 (5.8) |
Yes | 50 (35.2) | 36 (23.8) | 86 (29.4) | 41 (36.6) | 23 (21.1) | 64 (29.0) |
Ever admitted to hospital | ||||||
Missing | 4 | 5 | 9 | |||
Pubertal delay | ||||||
Yes | 8 (15.1) | 19 (26.8) | 27 (21.8) | 5 (11.4) | 14 (24.1) | 19 (18.6) |
Not eligible | 93 | 85 | 178 | 70 | 54 | 124 |